Introduction
Building on our previous annual report from 2023, we now present the 2024 edition of our Medical Device Market overview for Mexico.
This analysis continues to explore Mexico’s comparative performance in medical device importation and exportation, alongside insights into the country’s healthcare infrastructure and evolving market dynamics. With updated data and a fresh perspective, this report aims to clarify why Mexico remains a strategic hub for medical device activity, and why its position in Latin America continues to strengthen.
Market Overview: Mexico’s Import and Export Performance in 2024
Based on the latest data from Mexico’s central bank and corroborated by UN trade statistics, Mexico currently ranks 8th globally in medical device importation and holds the 4th position in exportation*, a showcase of its growing relevance in the global supply chain.
The table below provides a detailed breakdown of Mexico’s position among the top medical device importing countries worldwide.
|
Position |
Country |
|
1 |
USA |
|
2 |
Netherlands |
|
3 |
Germany |
|
4 |
China |
|
5 |
Japan |
|
6 |
France |
|
7 |
United Kingdom |
|
8 |
Mexico |
|
9 |
Italy |
|
10 |
Belgium |
|
11 |
Canada |
|
12 |
Spain |
|
13 |
Switzerland |
|
14 |
Australia |
|
15 |
India |
*Notes:
The information is obtained based on the most representative tariff codes related to medical devices (HS: 9018).
Data up to September 2025.
Regulatory Snapshot: Key Updates
2024 brought several noteworthy updates to Mexico’s medical device regulatory framework. Below are highlights of the most impactful changes, each linked to a deeper dive into the topic:
- Inside COFEPRIS Technical Sessions
- COFEPRIS Immediate Service Counter purpose and application process.
- Expanded Scope of COFEPRIS’s Immediate Service Counter – Rights Transfer Update
Note: Up to September 2025, the COFEPRIS Immediate Service Counter remains suspended. There is not an official communication whether if it will be reactivated.
Conclusions
Mexico’s sustained position as a global leader in medical device trade statistics is no longer just a trend, it is a strategic reality. The 2024 regulatory updates, including the expanded scope of COFEPRIS’s Immediate Service Counter and the deepening of technical sessions, signaled a clear commitment to regulatory agility and industry alignment. Nonetheless the counter was suspended in 2025, we are still experiencing a positive trend to expedite internal processes.
As we await further updates and data for 2025, we remain committed to keeping you informed. We hope this report has provided valuable insights. For additional details or tailored guidance, feel free to reach out to us at contact@veraqueconsulting.com.
To stay ahead of regulatory changes, market trends, and expert insights, subscribe to our newsletter and get updates delivered directly to your inbox.